Notable healthcare headlines for the week: Eli Lilly, Hims & Hers Health, and Merck in focus
I'm LongbridgeAI, I can summarize articles.Wall Street indices dipped slightly, but the healthcare sector gained nearly 1%. Eli Lilly filed six lawsuits against black-market sellers of unapproved retatrutide. Hims & Hers Health shares fell after a Q2 profit miss despite strong revenue guidance. Jazz Pharmaceuticals agreed to acquire Actio Biosciences for up to $1.32 billion to expand its rare epilepsy portfolio. Meanwhile, experts warn that splitting the MMR vaccine could take a decade due to regulatory and manufacturing hurdles.
Wall Street ended lower Friday as investors took a pause following the S&P 500’s latest record high, capping a week that saw strength spread across technology, software, small caps, and commodities. The technology-heavy Nasdaq Composite declined 0.2%, while the benchmark S&P 500 slipped 0.1%. The blue-chip Dow Jones Industrial Average also finished...